FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmaceutics and concerns a medical agent for treatment of chronic obstructive lung disease, the agent includes (A) glycopyrrolate and (B) (R)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyetyl] -8-hydroxy-1H-quinolin-2-one in free form or in the form of salt or solvate, with specified amount being intended for simultaneous, sequential or separate administration.
EFFECT: agent enhances therapy efficacy.
12 cl, 4 tbl, 233 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZOTHIAZOLE DERIVATIVES WITH PROPERTIES OF BETTA-2-ADRENORECEPTOR AGONISTS | 2003 |
|
RU2324687C2 |
| 5-HYDROXYBENZOTHIAZOLE DERIVATIVES AS β-ADRENORECEPTOR AGONISTS | 2005 |
|
RU2402540C2 |
| ENANTIOSELECTIVE METHOD FOR SYNTHESIS OF QUINOLINE DERIVATIVES | 2005 |
|
RU2383534C2 |
| PYRROLIDINIUM DERIVATIVES AS M3 MUSCARINIC RECEPTORS | 2005 |
|
RU2412183C2 |
| METHOD OF PRODUCTION OF 5-[(R)-2-(5,6-DIETHYLINDAN-2-YLAMINO)-1-HYDROXYETHYL]-8-HYDROXY-(1H)-QUINOLIN-2-ONE SALT WHICH IS USEFUL AS ADRENORECEPTOR AGONIST | 2004 |
|
RU2332405C2 |
| COMPOUNDS, METHOD FOR PREPARING COMPOUND, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244709C2 |
| METHOD FOR INHIBITION OF RAF KINASE-MEDIATED GROWTH OF TUMOR CELLS, HETEROCYCLIC UREA DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) | 1998 |
|
RU2232015C2 |
| METHOD OF 4-HYDROXYPROLINE SUBSTRUCTURE-CONTAINING COMPOUND SYNTHESIS | 2003 |
|
RU2392265C2 |
| USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
| LIQUID FORMULATIONS | 2006 |
|
RU2470631C2 |
